-
EP4185696
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4185696
| EP4185696 - OLIGONUCLEOTIDES TARGETING RNA BINDING PROTEIN SITES [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 28.04.2023 Database last updated on 19.10.2024 | |
| Former | The international publication has been made Status updated on 28.01.2022 | ||
| Former | unknown Status updated on 09.09.2021 | Most recent event Tooltip | 24.07.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 Basel / CH | [2023/22] | Inventor(s) | 01 /
EBELING, Martin 4070 Basel / CH | 02 /
JAGASIA, Ravi 4070 BASEL / CH | 03 /
JOENSON, Lars 2970 Hørsholm / DK | 04 /
LI, Meiling 4070 Basel / CH | 05 /
VIKESAA, Jonas 2970 Hørsholm / DK | 06 /
WANG, Congwei 4070 Basel / CH | 07 /
WEILE, Christian 2970 Hørsholm / DK | [2023/22] | Representative(s) | D Young & Co LLP 3 Noble Street London EC2V 7BQ / GB | [N/P] |
| Former [2023/22] | D Young & Co LLP 120 Holborn London EC1N 2DY / GB | Application number, filing date | 21762611.8 | 22.07.2021 | [2023/22] | WO2021EP70487 | Priority number, date | EP20200187354 | 23.07.2020 Original published format: EP 20187354 | [2023/22] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022018187 | Date: | 27.01.2022 | Language: | EN | [2022/04] | Type: | A1 Application with search report | No.: | EP4185696 | Date: | 31.05.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 27.01.2022 takes the place of the publication of the European patent application. | [2023/22] | Search report(s) | International search report - published on: | EP | 27.01.2022 | Classification | IPC: | C12N15/113 | [2023/22] | CPC: |
C12N15/113 (EP,US);
C12N2310/11 (EP,US);
C12N2310/315 (EP);
C12N2310/3231 (EP,US);
C12N2310/3341 (EP);
C12N2310/346 (EP);
C12N2320/33 (EP)
(-)
| C-Set: |
C12N2310/321, C12N2310/3521 (EP);
C12N2310/321, C12N2310/3525 (EP) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/22] | Title | German: | OLIGONUKLEOTIDE, DIE AUF RNA-BINDENDE PROTEINSTELLEN ABZIELEN | [2023/22] | English: | OLIGONUCLEOTIDES TARGETING RNA BINDING PROTEIN SITES | [2023/22] | French: | OLIGONUCLÉOTIDES CIBLANT DES SITES DE PROTÉINE DE LIAISON À L'ARN | [2023/22] | Entry into regional phase | 17.02.2023 | National basic fee paid | 17.02.2023 | Designation fee(s) paid | 17.02.2023 | Examination fee paid | Examination procedure | 17.02.2023 | Examination requested [2023/22] | 17.02.2023 | Date on which the examining division has become responsible | 05.10.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time | 08.12.2023 | Amendment by applicant (claims and/or description) | Request for further processing for: | 08.11.2023 | Request for further processing filed | 08.11.2023 | Full payment received (date of receipt of payment) Request granted | 19.12.2023 | Decision despatched | Loss of rights: Claims | 11.12.2023 | Request for further processing filed | 11.12.2023 | Full payment received (date of receipt of payment) Request granted | 19.12.2023 | Decision despatched | 08.12.2023 | Request for further processing filed | 08.12.2023 | Full payment received (date of receipt of payment) Request granted | 19.12.2023 | Decision despatched | Fees paid | Renewal fee | 20.07.2023 | Renewal fee patent year 03 | 23.07.2024 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XI]WO2017106283 (COLD SPRING HARBOR LABORATORY [US], et al); | [XDYI]WO2019241648 (IONIS PHARMACEUTICALS INC [US]); | [XI]WO2020097342 (ALIGOS THERAPEUTICS INC [US]); | [XPI]WO2020247419 (QURALIS CORP [US]); | [E]WO2021195446 (HARVARD COLLEGE [US], et al); | by applicant | WO9839352 | WO9914226 | WO0047599 | WO0066604 | WO0123613 | WO2004046160 | WO2007090071 | WO2007134181 | WO2008150729 | WO2008154401 | WO2009006478 | WO2009067647 | WO2010036698 | WO2010077578 | WO2011017521 | WO2011156202 | WO2013154798 | WO2014076195 | WO2015113922 | WO2019241648 |